Erythropoietin in HIE Neonate

ConditionNeonatal Hypoxic Ischemic Encephalopathy

Trial statusNot yet recruiting

Trial phaseEarly Phase 1

Trial typeInterventional

Biological sexAll

Age1-1

SponsorAssiut University

About this trial

this study is aim to delineate the role of erythropoietin in improving neonatal hypoxic ischemic encephalopathy the study is conducted to answer the question : is erythropoietin will improve neonatal hypoxic ischemic encephalopathy?

Eligibility criteria

Qualifiers

None

Disqualifiers

neonates who more than 1 month

neonates who suffer from brain insults other than HIE

Trial design

Treatments tested in this trial

Erythropoietin

Treatment groups

3 Participants

are divided into 3 treatment groups

Sponsors and collaborators

Assiut University

Lead sponsor

Source ClinicalTrials.gov